17
NEWS
MAKING AN IMPACT
Our Impact 2021, is a glossy snapshot of everything JDRF achieved last year.
Our Impact 2021 details how the charity has delivered on its three goals:
1. Drive research to cure, treat and prevent Type 1 diabetes
2. Accelerate access to Type 1 treatment technologies and medicines
3. Support people living with Type 1 diabetes
According to a spokesperson, "We couldn't have done any of this without
the generous support of the Type 1 community."
Download the publication here: www.jdrf.org.uk/impact-report-2021
3. Pumps and CGMs: ensuring
everyone living with Type 1
diabetes has access to technology
that automates glucose
monitoring and insulin delivery.
4. Prevention and cures: making the
case for further investment and
research in emerging prevention,
treatments and cures.
Once interventions are identified
on the global and country level,
the T1D Index encourages users to
take action by sharing the data and
findings with their networks and local
decision makers and connecting with
other people living with the condition
in their communities.
Additionally, the T1D Index
shines a light on important statistics
about the burden of Type 1 diabetes
globally, including the fact that, since
2000, Type 1 diabetes prevalence
has increased at four times the rate
of global population growth; the
expected number of people living
with Type 1 diabetes in 2040 is 17.43m.
The T1D Index is supported
by founding corporate sponsor,
Abbott Diabetes Care, with
additional support from Lilly, Vertex
Pharmaceuticals and The Leona M.
and Harry B. Helmsley Charitable
Trust. In future releases, the Index
will expand to include the impact of
Type 1 diabetes on economic costs,
mental health and quality of life
and broken down at regional and
demographic levels.
www.t1dindex.org